Barriers to Implementing Clinical Pharmacogenetics Testing in Sub-Saharan Africa. A Critical Review

Clinical research in high-income countries is increasingly demonstrating the cost- effectiveness of clinical pharmacogenetic (PGx) testing in reducing the incidence of adverse drug reactions and improving overall patient care. Medications are prescribed based on an individual’s genotype (pharmacogen...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Emiliene B. Tata, Melvin A. Ambele, Michael S. Pepper
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2020-08-01
Saila:	Pharmaceutics
Gaiak:	clinical pharmacogenetics pharmacogenetic testing adverse drug reactions genotype phenotype pharmacogene
Sarrera elektronikoa:	https://www.mdpi.com/1999-4923/12/9/809
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!